Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Buy
62
CALX Quote, Financials, Valuation and Earnings
Last price:
$40.27
Seasonality move
:
15.16%
Day range:
$40.00 - $40.71
52-week range:
$27.60 - $42.50
Dividend yield:
0%
P/E ratio:
605.41x
P/S ratio:
3.26x
P/B ratio:
3.44x
Volume:
901K
Avg. volume:
1M
1-year change:
45.03%
Market cap:
$2.6B
Revenue:
$831.5M
EPS (TTM):
-$0.52
Analysts' Opinion
-
Consensus RatingCalix has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $48.83, Calix has an estimated upside of 20.04% from its current price of $40.68.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $38.00 representing 100% downside risk from its current price of $40.68.
Fair Value
-
According to the consensus of 4 analysts, Calix has 20.04% upside to fair value with a price target of $48.83 per share.
CALX vs. S&P 500
-
Over the past 5 trading days, Calix has overperformed the S&P 500 by 6.68% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Calix does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Calix revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Calix reported revenues of $220.2M.
Earnings Growth
-
Calix earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Calix reported earnings per share of -$0.07.
Enterprise value:
2.4B
EV / Invested capital:
3.07x
Price / LTM sales:
3.26x
EV / EBIT:
116.57x
EV / Revenue:
2.85x
PEG ratio (5yr expected):
--
EV / Free cash flow:
45.05x
Price / Operating cash flow:
51.41x
Enterprise value / EBITDA:
239.15x
Gross Profit (TTM):
$453.7M
Return On Assets:
-3.74%
Net Income Margin (TTM):
-4.2%
Return On Equity:
-4.53%
Return On Invested Capital:
-4.53%
Operating Margin:
-2.76%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $932.9M | $1B | $825.5M | $226.3M | $220.2M | |
| Gross Profit | $471.7M | $512.8M | $453.7M | $122.6M | $122.7M | |
| Operating Income | $52.7M | $13.6M | -$47.1M | -$2M | -$6.1M | |
| EBITDA | $66.8M | $31.4M | -$28.1M | $2.8M | -$1.8M | |
| Diluted EPS | $0.61 | $0.31 | -$0.52 | -- | -$0.07 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $309.8M | $440.2M | $576.1M | $578.8M | $562M | |
| Total Assets | $468.1M | $775.2M | $914.8M | $922.8M | $917.1M | |
| Current Liabilities | $109.4M | $141.6M | $160.7M | $146.1M | $122.8M | |
| Total Liabilities | $153.4M | $183.4M | $197M | $180.1M | $150M | |
| Total Equity | $314.7M | $591.8M | $717.8M | $742.7M | $767.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $27.9M | $62.8M | $70.9M | $14.7M | $17.2M | |
| Cash From Investing | -$7.2M | $314K | -$101.8M | $3.3M | $11M | |
| Cash From Financing | $29.4M | -$69.1M | -$15.3M | $7.1M | -$29.1M | |
| Free Cash Flow | $12.5M | $45.9M | $52.3M | $11M | $12.9M | |
CALX
Sector
Market Cap
$2.6B
$78.3M
Price % of 52-Week High
95.72%
57.88%
Dividend Yield
0%
0%
Shareholder Yield
2.02%
0.76%
1-Year Price Total Return
45.03%
-18.18%
Beta (5-Year)
1.746
0.870
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$37.63
200-day SMA
Buy
Level
$36.27
Bollinger Bands (100)
Buy
Level
33.51 - 38.95
Chaikin Money Flow
Buy
Level
55.5M
20-day SMA
Buy
Level
$35.11
Relative Strength Index (RSI14)
Buy
Level
68.24
ADX Line
Buy
Level
22.79
Williams %R
Sell
Level
-0.3141
50-day SMA
Buy
Level
$35.63
MACD (12, 26)
Buy
Level
1.21
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
69M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.511)
Buy
CA Score
(Annual)
Level (1.041)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-2.8032)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.
Stock Forecast FAQ
In the current month, CALX has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CALX average analyst price target in the past 3 months is $48.83.
-
Where Will Calix Stock Be In 1 Year?
According to analysts, the consensus estimate is that Calix share price will rise to $48.83 per share over the next 12 months.
-
What Do Analysts Say About Calix?
Analysts are divided on their view about Calix share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Calix is a Sell and believe this share price will drop from its current level to $38.00.
-
What Is Calix's Price Target?
The price target for Calix over the next 1-year time period is forecast to be $48.83 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CALX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Calix is a Buy. 3 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CALX?
You can purchase shares of Calix via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Calix shares.
-
What Is The Calix Share Price Today?
Calix was last trading at $40.27 per share. This represents the most recent stock quote for Calix. Yesterday, Calix closed at $40.68 per share.
-
How To Buy Calix Stock Online?
In order to purchase Calix stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.45% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.98% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.93% over the past day.
